Journal
NATURE BIOTECHNOLOGY
Volume 25, Issue 2, Pages 238-243Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt1281
Keywords
-
Categories
Funding
- NIDDK NIH HHS [R21 DK069563, R21 DK069563-02] Funding Source: Medline
Ask authors/readers for more resources
The specialized microenvironment or niche where stem cells reside provides regulatory input governing stem cell function. We tested the hypothesis that targeting the niche might improve stem cell-based therapies using three mouse models that are relevant to clinical uses of hematopoietic stem ( HS) cells. We and others previously identified the osteoblast as a component of the adult HS cell niche and established that activation of the parathyroid hormone ( PTH) receptor on osteoblasts increases stem cell number(1-3). Here we show that pharmacologic use of PTH increases the number of HS cells mobilized into the peripheral blood for stem cell harvests, protects stem cells from repeated exposure to cytotoxic chemotherapy and expands stem cells in transplant recipients. These data provide evidence that the niche may be an attractive target for drug-based stem cell therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available